Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04541719

Patient Controlled Remifentanil Analgesia for Normal Labour

Patient Controlled Remifentanil Analgesia vs. Epidural Analgesia for Normal Labour. A Prospective Randomised Study

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Patient controlled remifentanil analgesia might offer comparative overall patient satisfaction and improved quality of analgesia after normal labour with continuous epidural analgesia.

Detailed description

We are aiming to study the effects of patient controlled remifentanil analgesia and epidural analgesia for normal labour in full term parturients on: * Peripartum analgesia * Overall patient's satisfaction * Maternal adverse effects * Neonatal outcomes

Conditions

Interventions

TypeNameDescription
DRUGPatient-controlled remifentanil analgesiaPatient controlled remifentanil analgesia with a regimen to provide a bolus of 40 μg remifentanil with a lockout interval of 2 min
DRUGEpidural analgesiaPatients will receive continuous epidural analgesia using bupivacaine 0.125% in conjunction with fentanyl 2 ug/ml at a rate of 8-15 ml/hr

Timeline

Start date
2017-04-01
Primary completion
2018-05-01
Completion
2018-07-01
First posted
2020-09-09
Last updated
2020-09-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04541719. Inclusion in this directory is not an endorsement.